The Stem Cell Research Enhancement Act of 2005 (HR 810) has been passed in a 238 to 194 vote in the US House of Representatives

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.479, 2005-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

US House of Representatives might welcome more research on embryo stem cells

By  

Reproductive BioMedicine Online, Vol. 11, Iss. 3, 2005-09 ,pp. : 339-339

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

The US Congress has passed the FDA Amendments Act of 2007

By  

Reactions Weekly, Vol. 1, Iss. 1171, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The state budget for healthcare in Vietnam has been set at $US802 million for 2005

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 469, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

US-based biopharmaceutical company NexBio, Inc. has been awarded a $US6 million phase II Small Business Innovation Research (SBIR) grant by the US NIAID

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 485, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

U.S. taxpayer dollars to support limited stem cell research

By Veeck LL  

Reproductive BioMedicine Online, Vol. 3, Iss. 2, 2001-09 ,pp. : 161-161

Reproductive Healthcare Ltd

Access to resources Recommend Favorite